Biologics in Autoimmune Diseases: A New Hope for Patients
Autoimmune diseases are complex and diverse, affecting millions of people globally with varying degrees of severity and symptoms. There are […]
Biosimilar Product Development: Regulatory Challenges & Key Insights
In this era where the demand for affordable healthcare is increasing every day, biosimilars that are replacements for biologics have
Document Management Systems (DMS) for Pharmaceutical Industry
A 21 CFR Part 11 compliance DMS is part of overall compliance and quality requirements across pharmaceutical organizations. Many tools
Bioconjugates: Combining the Best of Biologics and Small Molecules
Bioconjugates are molecules formed by chemically linking two or more molecules, typically involving a biological molecule like a protein, enzyme,
Global Regulation of Infant Formulas
Infant formula plays a crucial role in providing essential nutrition to infants who cannot be breastfed, helping to support their
Biosimilars vs. Generics: Key Differences and Market Implications
In pharmaceuticals, biosimilars and generics are two important categories that often come up in discussions about drug affordability and accessibility.
Drug Master File (DMF): Meaning, Submission & Guidelines
The critical information about the CMC (Chemistry, Manufacturing and Control) aspect of an active pharmaceutical ingredient or a finished pharmaceutical
What Is Investigational New Drug & Types Of IND
The governing federal law makes it a compulsion for the pharmaceuticals to be subject to the marketing application for their
Artixio Recognizes Femicura Healthtech as GEMi Grant Winner for Innovative Medtech Solutions
Artixio proudly announces Femicura Healthtech as the recipient of the prestigious GEMi (Grant for Early-Stage Medtech Innovations). The GEMi grant,